Literature DB >> 32661673

Cardiac amyloidosis CT sign.

Shahryar G Saba1,2,3, Michael P Gannon4, David T Majure5, Navid Rahmani6,7, Amar B Shah6,7, Christopher J Palestro6,7, Rakesh D Shah6,7.   

Abstract

Entities:  

Keywords:  Cardiac amyloidosis; Cardiovascular magnetic resonance; Computed tomography; Myocardial attenuation pattern; Myocardial hypoattenuation

Mesh：

Substances：

Year:  2020        PMID： 32661673     DOI： 10.1007/s00392-020-01693-y

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  9 in total

1.  New pathological insights into cardiac amyloidosis: implications for non-invasive diagnosis.

Authors:  Ornella Leone; Simone Longhi; Candida C Quarta; Teresa Ragazzini; Lucilla Badiali De Giorgi; Ferdinando Pasquale; Luciano Potena; Luigi Lovato; Agnese Milandri; Giorgio Arpesella; Claudio Rapezzi
Journal:  Amyloid       Date:  2012-05-17       Impact factor: 7.141

2.  Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.

Authors:  Hiromi Hashimura; Hatsue Ishibashi-Ueda; Yumiko Yonemoto; Keiko Ohta-Ogo; Taka-Aki Matsuyama; Yoshihiko Ikeda; Yoshiaki Morita; Naoaki Yamada; Hiroki Yasui; Hiroaki Naito
Journal:  Heart Vessels       Date:  2015-03-21       Impact factor: 2.037

3.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

4.  Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings.

Authors:  Waldemar Hosch; Arnt V Kristen; Martin Libicher; Thomas J Dengler; Sebastian Aulmann; Tobias Heye; Philip A Schnabel; Peter Schirmacher; Hugo A Katus; Hans-Ulrich Kauczor; Thomas Longerich
Journal:  Amyloid       Date:  2008-09       Impact factor: 7.141

5.  Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction.

Authors:  Selma F Mohammed; Sultan A Mirzoyev; William D Edwards; Ahmet Dogan; Donna R Grogan; Shannon M Dunlay; Veronique L Roger; Morie A Gertz; Angela Dispenzieri; Steven R Zeldenrust; Margaret M Redfield
Journal:  JACC Heart Fail       Date:  2014-04       Impact factor: 12.035

6.  Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study.

Authors:  Grigorios Chatzantonis; Michael Bietenbeck; Ahmed Elsanhoury; Carsten Tschöpe; Burkert Pieske; Gloria Tauscher; Julia Vietheer; Zornitsa Shomanova; Heiko Mahrholdt; Andreas Rolf; Sebastian Kelle; Ali Yilmaz
Journal:  Clin Res Cardiol       Date:  2020-11-10       Impact factor: 5.460

7.  Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis.

Authors:  Thomas A Treibel; Steve Bandula; Marianna Fontana; Steven K White; Janet A Gilbertson; Anna S Herrey; Julian D Gillmore; Shonit Punwani; Philip N Hawkins; Stuart A Taylor; James C Moon
Journal:  J Cardiovasc Comput Tomogr       Date:  2015-07-10

Review 8.  Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review.

Authors:  Philip Haaf; Pankaj Garg; Daniel R Messroghli; David A Broadbent; John P Greenwood; Sven Plein
Journal:  J Cardiovasc Magn Reson       Date:  2016-11-30       Impact factor: 5.364

9.  Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.

Authors:  Adam Castaño; David L Narotsky; Nadira Hamid; Omar K Khalique; Rachelle Morgenstern; Albert DeLuca; Jonah Rubin; Codruta Chiuzan; Tamim Nazif; Torsten Vahl; Isaac George; Susheel Kodali; Martin B Leon; Rebecca Hahn; Sabahat Bokhari; Mathew S Maurer
Journal:  Eur Heart J       Date:  2017-10-07       Impact factor: 29.983
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.